New Possibilities of Antibiotic Therapy for Blepharoconjunctivitis in Children

Author:

Efimova E. L.1ORCID,Brzheskiy V. V.1ORCID

Affiliation:

1. Saint-Petersburg State Pediatric Medical University

Abstract

The problem of drug therapy for bacterial eye infections in children has remained relevant for many years. The greatest interest of ophthalmologists in recent years is associated with the use of fluoroquinolones in the treatment of inflammatory eye diseases of the bacterial etiology. At the same time, new ophthalmic dosage forms of fluoroquinolones that have appeared in recent years naturally require additional research on their effectiveness.Objective: to study the clinical efficacy of the antibacterial drug Oftocypro (0.3 % cyprofloxacin in ophthalmic ointment) in the treatment of chronic blepharoconjunctivitis in children.Materials. The study involved 38 children aged 3 to 18 years (mean age 10.3 ± 2.7 years) with clinical manifestations of blepharoconjunctivitis. All patients were divided into 2 groups of equal size: 18 children (36 eyes) — with bacterial blepharoconjunctivitis and 20 (40) — with chlamydial blepharoconjunctivitis. The diagnosis was verified based on the clinical picture of blepharoconjunctivitis and laboratory data: detection of pathogenic microflora in the conjunctival cavity of patients of the first group and chlamydia antigen — in epithelial cells in scraping material from the conjunctiva by immunohistochemical analysis.Results. The analysis of the data obtained during the examination and treatment of children with blepharoconjunctivitis of bacterial etiology (group I), a reliable dynamics of controlled clinical and laboratory parameters was established. There was a significant positive dynamics of all controlled parameters of the clinical course of chronic bacterial blepharoconjunctivitis against the background of the drug Oftocipro ophthalmic ointment 0.3 % use. All children with chronic chlamydial blepharoconjunctivitis with the background of treatment with Oftocypro, ophthalmic ointment 0.3 %, showed a steady tendency towards relief of the estimated clinical signs of the disease. According to the results of laboratory studies, it was found that on the 28th day of treatment with Oftocypro chlamydia in the cells of the epithelium of the conjunctiva was re-detected in 4 out of 20 patients (20 %).Conclusion. The high efficacy of the drug Oftocypro ophthalmic ointment 0.3 %, in combination with the absence of pronounced side effects, makes it possible to recommend this drug for wider practical use.

Publisher

PE Polunina Elizareta Gennadievna

Subject

Ophthalmology

Reference17 articles.

1. Zaitseva M.V., Brzhesky V.V., Malysheva M.O. The possibility of instillation of a solution of moxifloxacin 0.5 % in the perioperative preparation in children. Russian Pediatric Ophthalmology = Rossiyskaya pediatricheskaya oftalmologiya. 2018;13(1):14–20 (In Russ.). DOI: 10.18821/1993-1859-2018-13-1-14-20

2. Andersson J., Hofsli M., Gade U.L. Use of topical ocular antibiotics in young children: a Scandinavian drug utilization study. Acta Ophthalmologica. 2018;96(8):789– 794. DOI: 10.1111/aos.13813

3. Vorontsova T.N., Mikhaylova M.V., Brzhesky V.V.. The sensitivity and resistance of microflora to antibacterial drugs of the conjunctival cavity in children. Ophthalmology in Russia = Oftalmologija. 2012;9(1):83–91 (In Russ.). DOI: 10.18008/1816-5095-2012-1-83-91

4. Neonatal conjunctivitis (neonatal ophthalmia, neonatal conjunctivitis). Neonatal Ophthalmology: A Manual for Physicians. Ed. V.V. Brzheskiy, D.O. Ivanov. Moscow: GEOTAR-Media, 2021. P. 115–127 (In Russ.).

5. Hua N., Ma W.J., Wang J.T. Normal conjunctival flora in healthy infants aged from 1 to 4 months. Chin. J. Ophthalmol. 2010;46:537–541.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3